Bicarbonate

Bicarbonate

SCHEMBL1080702

O=C(Nc1cccc(CC2CC2)c1)[C@H](c1ccc(CN2N=C(c3ccccc3)OCC2=O)cc1)C1CCCC1.O=C(O)O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PTGES O14684 7/20 0.48
HTR1E P28566 3/20 0.43
S1PR3 Q99500 3/20 0.43
MEN1 O00255 2/20 0.43
LMNA P02545 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.41
CCR3 P51677 3/20 0.40
MAOB P27338 2/20 0.38
ACKR3 P25106 2/20 0.37
PRKAA2 P54646 1/20 0.36
PTGS2 P35354 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12872141 0.92 PTGES (0.50) PTGESHTR1ES1PR3MEN1LMNA
Bicarbonate SCHEMBL1080560 0.90 PTGES (0.42) PTGESHTR1ES1PR3MEN1LMNA
SCHEMBL1079129 0.90 PTGES (0.60) PTGESHTR1ES1PR3MEN1LMNA
Bicarbonate SCHEMBL1080950 0.89 PTGES (0.38) PTGESCCR3MAOBACKR3PRKAA2
SCHEMBL12872122 0.89 PTGES (0.45) PTGESHTR1ES1PR3MEN1LMNA
SCHEMBL1193765 0.89 PTGES (0.55) PTGESHTR1ES1PR3MEN1LMNA
SCHEMBL1178561 0.89 PTGES (0.46) PTGESHTR1ES1PR3MEN1LMNA
SCHEMBL12871669 0.89 PTGES (0.46) PTGESHTR1ES1PR3MEN1LMNA
SCHEMBL1178961 0.88 PTGES (0.46) PTGESHTR1ES1PR3MEN1LMNA
SCHEMBL1079856 0.88 PTGES (0.45) PTGESHTR1ES1PR3MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268625-B1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF Bayer Pharma AG (DE) 2012-05-16 EP disclosed
EP-2268625-A1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-01-05 EP disclosed
WO-2009127338-A1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-10-22 WO disclosed